Invest in Assured Med Supply (AMS.AI)

AI Co-Pilot that could transform the $1.3 Trillion Medical Distribution Market

FIRST GOAL HIT (You can still invest)

$111,675

raised from 68 investors
INVESTMENT TERMS
Custom Contract
Investors will receive non-voting equity ownership in our Company based on a pre-raise valuation of $9 million.

Highlights

Repeat Founder

Founder has started a previous company funded with $2M+

1
Transforming the Future of the $1.3 Trillion Medical Distribution Industry with AI
2
Self-made success story: Prior to pivoting to AI, our medical supply business achieved $5M+ revenue
3
Our medical supply business had year-on-year growth of over 100% with no outside debt or investment
4
Al-powered healthcare solutions are projected to save Americans $150B annually by 2026

Featured Investor

Our Team


Who We Are

During our first three years working in the traditional medical supply industry, Assured Med Supply (AMS) achieved an annual growth rate of over 100% year-on-year without any outside financing or debt. We secured partnerships with top hospitals (ranked in the U.S. top 100) and multiple large Fortune 500 clients.

As seasoned medical industry insiders with a rare blend of tech expertise, we uncovered a major gap in the $1.3 trillion medical distribution market. Recognizing the immense potential to address the #2 biggest expense for hospitals, we recently made a decisive pivot into AI. This strategic leap empowers us to eliminate critical inefficiencies in the medical supply chain, leveraging our proven healthcare success and extensive client base. As a pure-play AI healthcare company with an elite AI team, we are ready to lead the medical supply industry into a new era of AI-driven innovation.

AMS Team Featured In




Sources: Harvard Business Review, Navigant, Medical Economics, Chief Healthcare



While growing our existing medical supply business, we realized that our past successes and AI experience uniquely position us to address many of these medical supply challenges with AI. Since 2023, we have been operating as a pure AI company, fully focused on developing technology such as:

  • AI Conversational Chat Interface – hospital and clinic buyers can communicate purchasing needs in real-time and receive immediate feedback for decision-making based on an AI-powered natural human language chat interface
  • Dynamic AI-Powered Marketplace – buyers can view available inventory across an aggregated set of pre-qualified vendors, receive automated price comparisons, and even benefit from dynamic group buying algorithms to further reduce costs
  • Visualization & Analysis AI Dashboards – buyers can review key information such as product substitution options and predictive analysis on delivery schedules and inventory pipelines to make better decisions on purchasing and inventory planning
  • Enterprise Integration – our platform integrates easily with dominant legacy ERP systems like SAP and major purchasing gateway systems like GHX to ensure ease of adoption for our healthcare customers



Future projections are not guaranteed.


AMS.AI Chatbot AI


Product Concept




Source: PWC





Distinct from many other startups, we have shown that we can successfully grow our Company. We also have several years of experience in the medical supply business space, and the added advantage of already having some of the world’s leading hospitals and medical companies as our customers. We plan to leverage our prior success and unique experience in medical supplies, AI chatbots, messaging, logistics, and marketplaces for a best-in-class solution.

The Revenue Model

  • AI–SaaS Subscriptions – hospital buyers pay an annual subscription fee for the intelligent AI marketplace, AI purchasing assistant, and smart analytics
  • AI Marketplace Platform Fees – medical vendors pay a percentage of the value of any sales they conduct via the marketplace platform


We aim to achieve over $20M of total revenue in the first two full years of our new AI platform operation, and project that we will scale to over $100M in 2028


Current Round Offering: $1,234,925









Downloads

Overview